Cardiovascular disease is a serious condition that causes
the death of approximately 900,000 individuals every year, accounting for 40%
of all deaths. Cardiovascular disease can include coronary artery disease,
congestive heart failure, arrhythmia, and a variety of other conditions. These
conditions can be life threatening if not managed properly. While many of these
conditions can be managed with medications, some of these typically require
surgical intervention such as cardiac bypass. In the past several decades,
percutaneous methods like angioplasty and stenting have become more common. In
these methods, access is gained using a femoral artery, and the vessel of
interest can be widened using a balloon or a stent. A stent, as this article
discusses, is a wire mesh tube that can help prop the artery open, decrease its
chances of narrowing, and improve blood flow. Some stents can be coated with
medication to decrease the likelihood of further coronary complications. These
medications most commonly include anticoagulants, which prevent blood clots,
myocardial infarctions, and strokes.
These metal stents are problematic because introducing metal
and other foreign objects can promote the formation of blood clots and the
development of scar tissue at the stent site. As a result of this issue, bioresorbable
stents were created with the intention of helping the artery heal in a more
natural manner with minimal scar tissue and other complications.
The U.S. Food and Drug Administration approved the first
bioresorbable stent just recently in July of 2016, calling it “Absorb.” However, it
seems that certain cardiologists like Dr. Mukherjee are skeptical of these
bioresorbable stents for multiple reasons. In a recent clinical trial, Absorb
was linked to an increased risk of blood clots forming on the actual stent. These
clots could detach from the stents and cause a heart attack, stroke, deep vein
thrombosis, pulmonary embolus, or other type of clot that compromises an area
of the body. Furthermore, bioresorbable stents are more costly, take longer to
insert, and are no safer than metal stents. In order to be more effective,
future bioresorbable stents will need to be absorbed quicker, and built with
thinner but stronger materials.
As Dr. Campisi would say, more research needs to be done...
https://www.sciencedaily.com/releases/2017/04/170406143847.htm
No comments:
Post a Comment